TECHNOLOGY:
A 10-second COVID-19 Antibody Test
AFFILIATION:
Carnegie Mellon University, Pittsburgh PA, Pittsburgh, Pennsylvania, United States
TECHNOLOGY SUMMARY
Area:
Diagnostic technologies for identification of SARS-CoV-2 from human nasal, buccal, or saliva samples
Tech Brief: A 10-second COVID-19 antibody test is developed representing fastest detection of this disease. The 3D printed sensor can be re-used at least 9-times and is connected to a smartphone interface for a convenient readout for at-home testing. Prototype devices have been demonstrated and looking for interest to productize the test.
SHOWCASE SUMMARY
Org Type:
Academic/Gov Lab
FIGURES OF MERIT
Value Proposition: The test will impact COVID-19 testing in the short term, while affecting medical diagnostics field in the long term. This is because the proprietary chemistries developed for this sensor to work can also be implemented for detection of biomarkers other pathogenic diseases such as Zika, Ebola, and HIV. Very importantly, you will be working with extremely enthusiastic inventors/entrepreneurs with can-do attitude and vast experience in productizing microelectronic device technologies. In addition, this test: • Is a breakthrough technology of antibody test that gives results in about 10 seconds • Provides a quantitative response to vaccination • Enables at-home testing • Large market potential in the United States as well as abroad – market of in the US is about $700 million/year • Platform technology with clear IP protection – can be extended to the detection of biomarkers for other pathogens • IRB approvals already obtained for large scale patient testing for FDA approval